eu uk skincare oem from product brief to market readiness-0

Solutions

Home >  Solutions

Back

EU & UK Skincare OEM | From Product Brief to Market Readiness

EU & UK Skincare OEM | From Product Brief to Market Readiness
EU & UK Skincare OEM Solution

From Product Brief to Market Readiness

A practical development route for skincare brands preparing products for the EU, Great Britain and Northern Ireland markets.

INTE supports formula development, factory documentation, testing coordination, packaging information and production readiness. The appointed Responsible Person and qualified safety assessor remain responsible for the final regulatory decision.

Market Readiness Starts Before Mass Production

EU and UK skincare projects involve more than formula development and manufacturing. The formula, ingredients, packaging, label information, testing plan and regulatory route need to be aligned before the product is released for commercial production.

INTE helps brands organize the factory-side and product-side information required for regulatory review, while keeping the responsibilities of the manufacturer, Responsible Person and safety assessor clearly separated.

01

Product Development

Translate a product brief, benchmark sample or product concept into a feasible formula and packaging direction.

02

Technical Documentation

Prepare manufacturing, ingredient, packaging and testing information for the appointed regulatory parties.

03

Production Readiness

Coordinate final formula confirmation, artwork review, testing status and production details before bulk manufacturing.

Clear Responsibilities. Fewer Misunderstandings.

A reliable OEM project should make it clear which information is provided by the factory and which decisions must be made by the appointed regulatory parties.

What INTE Provides

  • Formula and product information
  • Manufacturing process information
  • GMP / ISO 22716-related factory documentation
  • Product specifications and applicable COA information
  • Testing coordination and available reports
  • Packaging material and filling information
  • Technical information for PIF and CPSR preparation

What the RP and Safety Assessor Decide

  • Final cosmetic product safety assessment
  • CPSR and PIF approval
  • Final regulatory label approval
  • EU CPNP or GB SCPN notification
  • Market-specific claims review
  • Final market-entry compliance decision

INTE does not act as the Responsible Person. We provide the factory-side and product-side technical information required by the appointed Responsible Person and qualified safety assessor.

A Practical Route to Market Readiness

The most efficient projects do not wait until the end of development to consider compliance. Testing, packaging review and regulatory preparation should be planned alongside formula development.

Step 01 Product Brief

Confirm product category, target consumer, intended claims, target market, texture, ingredients and expected launch timing.

Step 02 Formula Direction

Review a new concept, existing formula or benchmark sample and confirm the appropriate development route.

Step 03 Packaging Planning

Review fill format, primary packaging, compatibility considerations, decoration and required label information.

Step 04 Testing Plan

Plan stability, microbiological, packaging compatibility and claims-supporting testing where relevant.

Step 05 RP Confirmation

Confirm the EU or GB Responsible Person and the address that will be used on the product packaging.

Step 06 Final Artwork

Review mandatory product information and approve print-ready artwork only after RP details are confirmed.

Step 07 Regulatory Review

Provide product information for CPSR, PIF, CPNP or SCPN preparation by the appointed regulatory parties.

Step 08 Production Release

Confirm formula, packaging, testing status, artwork and production details before commercial manufacturing.

Manufacturing Readiness: GMP and Factory Documentation

Before a skincare product moves into production, the factory-side information must be complete enough for the Responsible Person and safety assessor to review.

Manufacturing Information

  • Manufacturing process description
  • Production and filling information
  • Product specifications
  • Applicable COA information

Quality Documentation

  • GMP / ISO 22716-related documentation
  • Microbiological testing information
  • Stability testing information
  • Packaging compatibility information

Product Information

  • INCI and ingredient information
  • Raw material documents where available
  • Packaging material specifications
  • Claims-supporting information where applicable
Important: These documents support the regulatory review. They do not replace the CPSR, PIF, Responsible Person or qualified safety assessor.

Testing and Regulatory Preparation Run in Parallel

Regulatory preparation and product testing should not be treated as two completely separate stages. The testing plan should be considered while the formula and packaging are being finalized.

Testing May Include

  • Stability testing
  • Microbiological testing
  • Packaging compatibility testing
  • Product specification confirmation
  • Claims-supporting testing
  • Additional testing requested by the assessor

Before Commercial Production

  • The final formula has been confirmed
  • The preservative and fragrance system is confirmed
  • The final packaging configuration has been reviewed
  • The testing plan has been agreed
  • RP information is confirmed for the label
  • The regulatory review route is clear

Where relevant, testing should be carried out using the final formula and final packaging configuration. Changes after testing may require additional review or repeat testing.

Factory-Side Documents and Market-Specific Documents

A practical project separates the technical documents provided by the manufacturer from the market-specific documents finalized by the Responsible Person and safety assessor.

Factory-Side Document Package

  • GMP / ISO 22716-related factory documentation
  • Manufacturing process description
  • Product specifications
  • Applicable COA information
  • INCI and ingredient information
  • Raw material documentation where available
  • Microbiological information
  • Stability information
  • Packaging compatibility information
  • Packaging material specifications
  • Supplier declarations where available
  • Claims-supporting documentation where applicable

Market-Specific Regulatory Documents

  • EU or GB CPSR
  • EU or GB PIF
  • EU CPNP notification
  • GB SCPN notification
  • Final regulatory label review
  • Market-specific claims review
  • Responsible Person confirmation
  • Final market-entry approval

Confirm the Responsible Person Before Final Artwork

One of the most common sources of avoidable packaging rework is approving the label before the Responsible Person has been confirmed.

01

Confirm the Market

Decide whether the product is intended for the EU, Great Britain, Northern Ireland or multiple markets.

02

Confirm the RP

Confirm the legal name and address of the appointed Responsible Person before approving final artwork.

03

Approve the Label

Review mandatory product information and only then release the artwork for printing and production.

Practical recommendation: Lock the Responsible Person details before the packaging artwork becomes print-ready. If the RP information changes later, the packaging may require rework.

EU, GB and NI Are Separate Compliance Routes

EU, Great Britain and Northern Ireland should not be treated as one single regulatory route. The Responsible Person, notification process and safety review should be confirmed according to the actual destination market.

Market Main Notification Route Responsible Person and Review
EU Member States CPNP An EU-established Responsible Person handles the applicable EU notification and regulatory responsibilities.
Great Britain SCPN A UK-established Responsible Person is required. The product requires a GB-specific regulatory review.
Northern Ireland Separate route assessment The applicable EU or NI route should be confirmed separately according to the product and market arrangement.

An EU CPSR should not be assumed to automatically cover Great Britain. The product should undergo a GB-specific review, adaptation or re-signing where required by the qualified safety assessor and UK Responsible Person.

INTE does not act as the Responsible Person. We provide the product, manufacturing and technical information required by the appointed regulatory parties.

EU CPNP Notification and the Frame Formulation

For products placed on the EU market, the EU Responsible Person is responsible for submitting the required product information to the Cosmetic Products Notification Portal, or CPNP, before the product is placed on the market.

Product Identification

Product name, category, Responsible Person details and the market in which the product will be made available.

Formula Information

The applicable formula information and, where required, the frame formulation for emergency medical treatment.

Confidential Handling

Formula-related information is handled between the brand, manufacturer and regulatory parties under agreed confidentiality arrangements.

The frame formulation is not the same as publishing the full commercial formula. INTE can prepare and provide the relevant product information required for regulatory review, while the EU Responsible Person remains responsible for the final CPNP notification.

Animal-Testing Compliance and Supply-Chain Evidence

For EU market entry, animal-testing compliance should be considered at both finished-product and ingredient level.

Information That May Be Reviewed

  • Finished cosmetic product information
  • Ingredient and raw material information
  • Supplier declarations
  • Available raw material traceability
  • Historical testing information
  • Relevant supply-chain statements

How INTE Supports the Review

  • Coordinate available supplier documentation
  • Provide relevant factory-side information
  • Help organize ingredient and product records
  • Support communication with the appointed assessor
  • Clarify which documents are available for the project
  • Respect the final decision of the RP and assessor

INTE can coordinate available supplier declarations and traceability documents for review. The final interpretation and acceptance of the evidence must be made by the Responsible Person and qualified safety assessor.

Five Checks Before Final Production

Before approving mass production, we recommend confirming the following items with your project team and regulatory partners.

01

Responsible Person

The EU or GB Responsible Person has been appointed and the legal address is confirmed.

02

Final Formula

The formula, ingredients, fragrance and preservative system have been finalized.

03

Final Packaging

The primary packaging and compatibility requirements have been reviewed.

04

Testing Plan

Stability, microbiological, compatibility and claims-supporting testing has been planned where relevant.

05

Market Route

The EU, GB or NI route has been clearly defined and the required regulatory parties are aligned.

06

Artwork Approval

The mandatory label information has been reviewed before the artwork is released for printing.

Frequently Asked Questions

Does INTE act as the EU or GB Responsible Person?

No. INTE does not act as the Responsible Person. We provide factory-side and product-side technical information for the appointed Responsible Person and qualified safety assessor.

Can the same CPSR be used for both the EU and GB?

An EU CPSR should not be assumed to automatically cover Great Britain. The project should be reviewed for GB requirements and adapted or re-signed where required by the qualified safety assessor and UK Responsible Person.

When should the Responsible Person be confirmed?

The Responsible Person should ideally be confirmed before the final packaging artwork is approved. The RP name and address may need to appear on the product packaging.

What is a frame formulation?

A frame formulation is formula information used for the EU notification process and intended to support prompt and appropriate medical treatment in the event of difficulties. It is not the same as publishing the full commercial formula.

When should testing begin?

Testing should be planned during formula and packaging development. Where relevant, final testing should use the final formula and final packaging configuration.

Can INTE provide GMP-related documents?

INTE can provide relevant factory-side GMP / ISO 22716-related documentation and manufacturing information for regulatory review, subject to the project scope and the applicable certified manufacturing entity.

Can INTE support animal-testing compliance documentation?

INTE can coordinate available supplier declarations, traceability documents and factory-side information for review. Final interpretation and acceptance remain with the Responsible Person and qualified safety assessor.

Start Your EU or UK Skincare Project

Share your product concept, target market, preferred formula or benchmark, packaging direction, expected quantity and target launch date. Our team will help you identify the appropriate development, testing and manufacturing route.

Request an EU/GB Readiness Review
This page describes INTE’s factory-side and product-side technical support. It is not legal advice and does not replace the review, approval or filing responsibility of the appointed Responsible Person and qualified safety assessor.
Prev

None

ALL

Centella Sensitive Skin Skincare Line | 7-Day Sample Development

Next
Recommended Products
WhatsApp WhatsApp Email Email Mobile Mobile TopTop